3Guariguata L, Whiting DR, Hambleton I, et al. Global estimates of diabetes prevalence for 2013 and projections for 2035 for the IDF Diabetes Atlas[ J]. Diabetes Res Clin Pract, 2013, 103: 137-149.
4Singh N, Armstrong DG, Lipsky BA. Preventing foot ulcers in patients with diabetes [ J ]. JAMA,2005,293:217-228.
5Prompers L, Huijberts M, Schaper N, et al. Resource utilisation and costs associated with the treatment of diabetic foot ulcers. Prospective data from the Eurodiale Study[ J]. Diabetologia,2008, 51:1826-1834.
6Wild S,Roglic G, Green A, et al. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030 [J]. Diab Care ,2004,27 : 1047-1053.
7Fard AS,Esmaelzadeh M,Larijani B. Assessment and treatment of diabetic foot ulcer[ J]. Int J Clin Pract,2007,61:1931-1938.
8Lavery LA,Armstrong DG, Wunderlich RP, et al. Risk factors for foot infection in individuals with diabetes [ J ]. Diabetes Care, 2006,29 : 1288-1293.
9Wagner FW. The dysvascular foot: A system for diagnosis and treatment[ J]. Foot Ankle, 1981,2:64-122.
